The MPN Leaders Programme is a fully immersive, educational development programme aiming to support emerging haematology leaders specialising in the field of myeloproliferative neoplasms (MPN).
Designed by a steering committee of leading MPN specialists, in collaboration with Novartis, this multi-step programme presents a unique opportunity to gain experience of working in, and contributing to, the field of MPN, and to engage with renowned senior clinical leaders.
The programme focuses on the following key themes:
Knowledge sharing and case review
Expert support and guidance
Clinical data review and analysis
Educational plenary presentations
The MPN Leaders Programme is organised and funded by Novartis Pharmaceuticals UK Ltd and is classed as promotional under the Association of the British Pharmaceutical Industry (ABPI) Code. Prescribing information will be available throughout the programme for all Novartis brands mentioned. Participation in the programme will be funded by Novartis (delegate travel, accommodation and reasonable expenses will be covered in the event of a face-to-face meeting). The Steering Committee has been offered an honorarium for their involvement in this programme.
MDT, multidisciplinary team.